Interleukin-6-controlled, mesenchymal stem cell-based sodium/iodide symporter gene therapy improves survival of glioblastoma-bearing mice.
Kitzberger C, Shehzad K, Morath V, Spellerberg R, Ranke J, Steiger K, Kälin RE, Multhoff G, Eiber M, Schilling F, Glass R, Weber WA, Wagner E, Nelson PJ, Spitzweg C.
Kitzberger C, et al. Among authors: shehzad k.
Mol Ther Oncolytics. 2023 Aug 15;30:238-253. doi: 10.1016/j.omto.2023.08.004. eCollection 2023 Sep 21.
Mol Ther Oncolytics. 2023.
PMID: 37701849
Free PMC article.